Results show Pipeline device offers safe and effective treatment of large and giant aneurysms
MANSFIELD, Mass. - Tuesday, June 18th 2013 [ME NewsWire]
(BUSINESS WIRE)-- Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline™ embolization device have been published in the June issue of Radiology.1 Radiology is the official peer-reviewed medical journal of the Radiological Society of North America.
The Pipeline device met the trial’s primary endpoints for both effectiveness and safety. Based on these data, the Pipeline device was approved by the U.S. Food and Drug Administration (FDA) on April 6, 2011.
"Patients with an unruptured large or giant wide-necked aneurysm in the internal carotid artery are at significant risk of death or a highly disabling stroke and other significant neurologic complications if the aneurys
...
Read more »